BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12955073)

  • 1. CrkII induces serum response factor activation and cellular transformation through its function in Rho activation.
    Iwahara T; Akagi T; Shishido T; Hanafusa H
    Oncogene; 2003 Sep; 22(38):5946-57. PubMed ID: 12955073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galphaz inhibits serum response factor-dependent transcription by inhibiting Rho signaling.
    Dutt P; Jaffe AB; Merdek KD; Hall A; Toksoz D
    Mol Pharmacol; 2004 Dec; 66(6):1508-16. PubMed ID: 15326221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways.
    Martin CB; Mahon GM; Klinger MB; Kay RJ; Symons M; Der CJ; Whitehead IP
    Oncogene; 2001 Apr; 20(16):1953-63. PubMed ID: 11360179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G2A is an oncogenic G protein-coupled receptor.
    Zohn IE; Klinger M; Karp X; Kirk H; Symons M; Chrzanowska-Wodnicka M; Der CJ; Kay RJ
    Oncogene; 2000 Aug; 19(34):3866-77. PubMed ID: 10951580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways.
    Hernandez-Muñoz I; Malumbres M; Leonardi P; Pellicer A
    Oncogene; 2000 May; 19(23):2745-57. PubMed ID: 10851075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF.
    Akakura S; Kar B; Singh S; Cho L; Tibrewal N; Sanokawa-Akakura R; Reichman C; Ravichandran KS; Birge RB
    J Cell Physiol; 2005 Jul; 204(1):344-51. PubMed ID: 15700267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of serum response element by D2 dopamine receptor is governed by Gbetagamma-mediated MAPK and Rho pathways and regulated by RGS proteins.
    Ho G; Wang Y; Jones PG; Young KH
    Pharmacology; 2007; 79(2):114-21. PubMed ID: 17179741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF.
    Suzuki N; Nakamura S; Mano H; Kozasa T
    Proc Natl Acad Sci U S A; 2003 Jan; 100(2):733-8. PubMed ID: 12515866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the c-fos serum response element by phosphatidyl inositol 3-kinase and rho pathways in HeLa cells.
    Wang Y; Falasca M; Schlessinger J; Malstrom S; Tsichlis P; Settleman J; Hu W; Lim B; Prywes R
    Cell Growth Differ; 1998 Jul; 9(7):513-22. PubMed ID: 9690619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Lbc RhoGEF in Galpha12/13-induced signals to Rho GTPase.
    Dutt P; Nguyen N; Toksoz D
    Cell Signal; 2004 Feb; 16(2):201-9. PubMed ID: 14636890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein kinase D3 by signaling through Rac and the alpha subunits of the heterotrimeric G proteins G12 and G13.
    Yuan J; Rey O; Rozengurt E
    Cell Signal; 2006 Jul; 18(7):1051-62. PubMed ID: 16198087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small GTP-binding protein Rho links G protein-coupled receptors and Galpha12 to the serum response element and to cellular transformation.
    Fromm C; Coso OA; Montaner S; Xu N; Gutkind JS
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10098-103. PubMed ID: 9294169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the SRF gene occurs through a Ras/Sp/SRF-mediated-mechanism in response to serum growth signals.
    Spencer JA; Misra RP
    Oncogene; 1999 Dec; 18(51):7319-27. PubMed ID: 10602487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GTPase deficient mutant of G(alpha13) regulates the expression of Egr-1 through the small GTPase Rho.
    Vara Prasad MV; Dhanasekaran N
    Oncogene; 1999 Feb; 18(8):1639-42. PubMed ID: 10102635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insert region of RhoA is essential for Rho kinase activation and cellular transformation.
    Zong H; Kaibuchi K; Quilliam LA
    Mol Cell Biol; 2001 Aug; 21(16):5287-98. PubMed ID: 11463812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIM, a Dbl-related protein, regulates cell shape and cytoskeletal organization in a Rho-dependent manner.
    Xie X; Chang SW; Tatsumoto T; Chan AM; Miki T
    Cell Signal; 2005 Apr; 17(4):461-71. PubMed ID: 15601624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two signaling submodules within the CrkII/ELMO/Dock180 pathway regulating engulfment of apoptotic cells.
    Tosello-Trampont AC; Kinchen JM; Brugnera E; Haney LB; Hengartner MO; Ravichandran KS
    Cell Death Differ; 2007 May; 14(5):963-72. PubMed ID: 17304244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGS16 inhibits signalling through the G alpha 13-Rho axis.
    Johnson EN; Seasholtz TM; Waheed AA; Kreutz B; Suzuki N; Kozasa T; Jones TL; Brown JH; Druey KM
    Nat Cell Biol; 2003 Dec; 5(12):1095-103. PubMed ID: 14634662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for VASP in RhoA-Diaphanous signalling to actin dynamics and SRF activity.
    Grosse R; Copeland JW; Newsome TP; Way M; Treisman R
    EMBO J; 2003 Jun; 22(12):3050-61. PubMed ID: 12805219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.